Literature DB >> 11397951

Risk factors for failure to meet listing requirements in liver transplant candidates with alcoholic cirrhosis.

J F Karman1, P Sileri, D Kamuda, L Cicalese, C Rastellini, T E Wiley, T J Layden, E Benedetti.   

Abstract

BACKGROUND: The majority of liver transplant centers require a 6-month abstinence period before listing candidates for liver transplantation with alcoholic cirrhosis and a persistent sobriety thereafter. We attempted to identify risk factors for failure to comply with these requirements.
METHODS: Ninety-nine consecutive patients with alcoholic cirrhosis were referred for liver transplant evaluation between September 1996 and May 1998. The mean age was 49 years, 74% were male, and 54% were hepatitis C virus positive. To be listed, patients had to meet the following requirements. All patients received extensive psychosocial evaluations and were frequently monitored with random urine and blood alcohol tests; patients found positive were excluded or removed from the liver transplant waiting list. Detailed patient information was entered into a computerized database, and 36 discreet variables were analyzed in relation to success (patient listed and remained on the list) or failure (not listed or removed from the list based on noncompliance).
RESULTS: Forty-nine patients were successfully listed. Nineteen received a transplant, with a 95% 1-year patient and graft survival rate and 21% alcohol relapse rate after transplantation. Twenty-two patients had either medical contraindication and/or died before transplant listing. Twenty-four patients were never listed and four were removed from the list due to recurrent alcoholism, for a total of 28 failures. Our statistical analysis identified five significant risk factors for failure: (I) living arrangement (alone/family versus community/friend), P=0.006; (II) history of suicide ideation, P=0.03; (III) history of previous alcohol-related hospitalization, P=0.01; (IV) lack of previous alcoholic rehabilitation before transplant evaluation, P=0.001; and (V) failure to accept further alcoholic rehabilitation before orthotopic liver transplantation, P=0.01.
CONCLUSIONS: Our experience confirms that transplantation can be extremely successful in properly selected patients with alcoholic cirrhosis. We identified several predictive psychosocial factors of early alcoholic recidivism in transplant candidates.

Entities:  

Mesh:

Year:  2001        PMID: 11397951     DOI: 10.1097/00007890-200105150-00005

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

Review 1.  When alcohol abstinence criteria create ethical dilemmas for the liver transplant team.

Authors:  K A Bramstedt; N Jabbour
Journal:  J Med Ethics       Date:  2006-05       Impact factor: 2.903

Review 2.  Long-term survival after liver transplantation for alcoholic liver disease.

Authors:  Paula Iruzubieta; Javier Crespo; Emilio Fábrega
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

3.  Transcranial Magnetic Stimulation and Deep Brain Stimulation in the treatment of alcohol dependence.

Authors:  L Alba-Ferrara; F Fernandez; R Salas; G A de Erausquin
Journal:  Addict Disord Their Treat       Date:  2014-12

Review 4.  Advances in alcoholic liver disease: An update on alcoholic hepatitis.

Authors:  Randy Liang; Andy Liu; Ryan B Perumpail; Robert J Wong; Aijaz Ahmed
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 5.  Predictors of Alcohol Relapse Following Liver Transplantation for Alcohol-Induced Liver Failure. Consideration of "A-D" Selection Criteria.

Authors:  Annie Gong; Gerald Y Minuk
Journal:  Ann Transplant       Date:  2018-02-20       Impact factor: 1.530

6.  Alcohol relapse and its predictors after liver transplantation for alcoholic liver disease: a systematic review and meta-analysis.

Authors:  Lancharat Chuncharunee; Noriyo Yamashiki; Ammarin Thakkinstian; Abhasnee Sobhonslidsuk
Journal:  BMC Gastroenterol       Date:  2019-08-22       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.